EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Yidu Tech Inc (2158) fair value: what the stock is really worth

As of Sep 30, 2026: fair value of Yidu Tech Inc HK$1.83, price HK$3.44, upside -46.8%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · HK · ISIN KYG9845C1069

YT Thin data Sep 27, 2026

Yidu Tech Inc

2158 · HK

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value HK$1.83 · Strongly overvalued (−46.8%)
!Quality 53/100
!Weak Growth (revenue 5y −1.8 %/yr)
!Thin margins · 8.9% net margin (TTM)
!Low debt · negative free cash flow
!Mixed vs. peers (7/12)
!Moderate moat 50/100
!Evidence only low, so the estimate is less certain
!Weak on past: 8 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$47.95 HK$2.86 Fair Value HK$1.83 May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range HK$2.86 – HK$47.95 · fair‑value band HK$1.28 – HK$1.93 · the HK$3.44 price screens above the HK$1.83 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Yidu Tech in your weekly email

Every Wednesday you see whether Yidu Tech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People's Republic of China, Brunei, Singapore, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions segments.

Show more

Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People's Republic of China, Brunei, Singapore, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions; AI solutions for a range of medical treatment, education, research, and hospital management scenarios; all disease data platforms; and operates a data center under the Eywa name for hospitals and medical institutions. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world study and evidence, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; operation of YiduCore, an AI medical brain, that extracts, structures, and standardizes the raw and dispersed medical data and transforms it into deep medical insights and practical solutions; distribution of insurance companies' products; and sale of pharmaceutical products and related hardware and other services, as well as offers personalized digital therapies and out-of-hospital care services. It also engages in the sale of medical devices; provision of insurance brokerage and technology services; and medical and computer technology research and development. The company serves healthcare industry participants, including hospitals, research institutions, insurance companies, doctors, patients, and regulators and policy makers, as well as pharmaceutical, biotech, and medical device companies. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China.

Stock analysis

Yidu Tech Inc (2158) currently trades at HK$3.44, while our model-based Fair Value estimate is HK$1.83, 46.8% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of HK$2.39 per share, and 0 of the 10 models we run sit above the HK$3.44 price.

Bear case: the DCF Models group reads lowest at HK$0.9700, and 10 of the 10 models stay below the price. Evidence for this calculation is low.

Scenario range: HK$1.28 (bear) to HK$1.93 (bull), the price of HK$3.44 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Yidu Tech Inc reported revenue of HK$791M in FY2026 versus HK$1.2B in FY2022, a compound −10.6%/yr. Reported net income was HK$70.2M in FY2026.

Key figures

Market cap HK$5.0B (≈ $633M) · P/E ratio 60.9 · P/S ratio 5.40 · EPS (TTM) HK$−0.0800 · Net margin 8.9% · Return on equity 2.1% · Return on assets (EBIT) −7.6% · Operating margin 41.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 52% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −47%, 2158 screens richer than that median.

Fair Value models

Bear HK$1.28 Fair Value HK$1.83 Bull HK$1.93
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings HK$0.8200 HK$0.9700 HK$1.25 78
Residual Income HK$2.35 HK$2.17 HK$2.10 71
Growth-Adj P/E HK$1.28 HK$1.83 HK$2.38 67
All 10 models by family
DCF Models
Owner Earnings HK$0.8200 HK$0.9700 HK$1.25 78
Earnings-Based
Graham-Dodd HK$0.4700 HK$3.08 HK$4.31 63
Lynch FV HK$0.9000 HK$1.28 HK$1.67 61
PEG = 1.0 HK$0.9000 HK$1.28 HK$1.67 57
Multiples
P/E Multiple HK$1.14 HK$1.51 HK$1.89 63
P/S Multiple HK$0.8800 HK$1.17 HK$1.46 58
P/B Multiple HK$0.8800 HK$1.17 HK$1.46 55
Asset-Based
NCAV (Graham) HK$1.78 HK$2.39 HK$3.56 54
Economic Profit
Residual Income HK$2.35 HK$2.17 HK$2.10 71
Growth Earnings
Growth-Adj P/E HK$1.28 HK$1.83 HK$2.38 67

Open the full fair value analysis →

Notify me when 2158 reaches fair value

Put 2158 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 53/100

Of which business quality 49 · Market factors (momentum, volatility) 11

Profitability 21
Margins and returns on capital today
Quality Growth 78
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 86
Balance sheet, leverage, solvency risk
Investment 80
Disciplined investing over empire-building
Low Volatility 33
Calm price path (market factor)
Momentum 3
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 54
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 20/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+10.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.8%
Start year 2021 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−52.3% (2021) → −11.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

2158 screens overvalued: fair value 47% below the price. Compare with Veeva Systems Inc →

Compare Yidu Tech Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 129 stocks

Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside −46.8% · Below median
Profitability
Return on equity (TTM) 2.1% · Above median
Return on assets 1.2% · Above median
Net margin (TTM) 8.9% · Above median
Operating margin (TTM) 41.7% · Top 25%
Growth and dividend
Revenue growth 19.6% · Above median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 60.9× · Priciest 25%
P/B 1.37× · Cheaper than median
P/S (TTM) 6.06× · Priciest 25%
EV/EBITDA 37.0× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)98 · sector 36
PAST (return on equity)8 · sector 7
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 45

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $278.57 $306.43 +10%
Pro Medicus Limited PME A$161.00 A$84.62 −47%
BrightSpring Health Services, Inc BTSG $56.54 $25.86 −54%
Hinge Health, Inc HNGE $95.57 $51.25 −46%
HealthEquity, Inc HQY $88.44 $97.28 +10%
Waystar Holding WAY $24.70 $27.17 +10%
Doximity, Inc DOCS $26.35 $31.41 +19%
Inventurus Knowledge Solutions Limited IKS ₹1,779 ₹1,883 +6%
Privia Health Group PRVA $19.62 $5.02 −74%
Winning Health Technology Group 300253 ¥6.98 ¥3.44 −51%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Yidu Tech Inc Fair Value". https://www.fairvalue-calculator.com/stock/2158

Frequently asked questions

Is Yidu Tech Inc (2158) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of HK$1.83 versus a price of HK$3.44, about −47% upside (overvalued).
What is the fair value of 2158?
Our model-based fair value for Yidu Tech Inc is HK$1.83 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$3.44.
What is the quality score of 2158?
Yidu Tech Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Yidu Tech Inc (2158)?
Our model-based price target is the fair value of HK$1.83 (as of Sep 27, 2026) from 10 valuation models. Cautious scenario HK$1.28, optimistic scenario HK$1.93. It is a calculation from audited fundamentals, not an analyst target.
What is the Yidu Tech Inc stock forecast for 2026?
Our models put fair value at HK$1.83, about −47% upside versus a price of HK$3.44 (overvalued). Cautious scenario HK$1.28, optimistic scenario HK$1.93. The calculation is refreshed regularly with new filings.
What is the revenue of Yidu Tech Inc (2158)?
Yidu Tech Inc reported trailing-twelve-month revenue of about HK$819M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Yidu Tech Inc (2158)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Yidu Tech Inc it is HK$1.83 per share (as of Sep 27, 2026), against a price of HK$3.44. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Yidu Tech Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 2158 trades above its calculated fair value: price HK$3.44, fair value HK$1.83, a gap of about −47% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 2158?
No. The price is what the market pays today (HK$3.44); the fair value is what the company's own numbers justify (HK$1.83). For Yidu Tech Inc the two are HK$1.61 per share apart. That gap is exactly why we show both numbers side by side.
How much is Yidu Tech Inc worth?
The market values Yidu Tech Inc at about HK$5.0B (market capitalisation, as of Sep 27, 2026). Per share that is HK$3.44; our models calculate a fair value of HK$1.83 per share.
What do the bullish and bearish scenarios say about 2158?
Our models span a range for Yidu Tech Inc: cautious scenario HK$1.28, base HK$1.83, optimistic HK$1.93 per share (as of Sep 27, 2026, price HK$3.44). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 2158?
Yidu Tech Inc trades at a price-to-earnings ratio of 60.9 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$1.83 is built from several models across several years. Other multiples: P/B 1.4, P/S 6.1, EV/EBITDA 37.0.
How solid is the balance sheet of Yidu Tech Inc (2158)?
Balance-sheet figures for Yidu Tech Inc (as of Sep 27, 2026): return on equity 2.1%. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is 2158 from its 52-week high?
Yidu Tech Inc trades at HK$3.44, about 52% below its 52-week high of HK$7.14 and 3% above the low of HK$3.34 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of HK$1.83 is for.
Which stocks are comparable to Yidu Tech Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Yidu Tech Inc stock attractive at the current price?
The data as of Sep 27, 2026: price HK$3.44, calculated fair value HK$1.83 (−47%), Quality Score 53/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 2158 calculated?
We run Yidu Tech Inc through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$1.83, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. Yidu Tech Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Yidu Tech Inc (2158)?
The closing price on Sep 30, 2026 was HK$3.44. Our model-based fair value is HK$1.83, about −47% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Yidu Tech Inc right now?
The price sits above even our optimistic bull case (HK$1.93). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Yidu Tech Inc

How large is the market capitalisation of Yidu Tech Inc (2158)?
The market capitalisation of Yidu Tech Inc is HK$5.0B (≈ $633M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Yidu Tech Inc (2158)?
The price-to-sales ratio of Yidu Tech Inc is 5.40 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Yidu Tech Inc (2158)?
Earnings per share at Yidu Tech Inc are HK$−0.0800 (price ÷ EPS = P/E 60.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Yidu Tech Inc (2158)?
The net margin of Yidu Tech Inc is 8.9% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Yidu Tech Inc (2158)?
The return on equity (ROE) of Yidu Tech Inc is 2.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Yidu Tech Inc (2158)?
On an EBIT basis the return on assets of Yidu Tech Inc is −7.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Yidu Tech Inc (2158)?
The operating margin of Yidu Tech Inc is 41.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Yidu Tech Inc (2158)?
Revenue at Yidu Tech Inc is growing +19.6% versus a year earlier (3y avg −0.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Yidu Tech Inc (2158) generate?
The free cash flow of Yidu Tech Inc is −HK$351M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Yidu Tech Inc (2158) hold?
Yidu Tech Inc holds more cash than debt, HK$596M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Yidu Tech Inc in the live analysis

One click puts Yidu Tech Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.